Provided by Tiger Trade Technology Pte. Ltd.

CRISPR Therapeutics AG

55.44
+0.12000.22%
Post-market: 55.510.0700+0.13%19:30 EDT
Volume:1.06M
Turnover:58.95M
Market Cap:5.36B
PE:-11.65
High:56.59
Open:55.45
Low:54.82
Close:55.32
52wk High:78.48
52wk Low:44.12
Shares:96.69M
Float Shares:93.17M
Volume Ratio:0.80
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7595
EPS(LYR):-6.4700
ROE:-26.09%
ROA:-14.20%
PB:3.07
PE(LYR):-8.57

Loading ...

CRISPR Therapeutics Q1 net loss narrows to $122.9 million; revenue hits $43 million

Reuters
·
May 05

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 05

Press Release: Morningstar Reaches New Milestone in the CRSP Acquisition, Rebranding CRSP Market Indexes to Morningstar Indexes

Dow Jones
·
Apr 29

Intellia Therapeutics Reports Positive Phase 3 Trial Results for CRISPR-Based Gene Therapy

Deep News
·
Apr 27

Is CRISPR Therapeutics (CRSP) Share Price Aligning With Its Long Term Growth Story?

Simply Wall St.
·
Apr 24

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

GlobeNewswire
·
Apr 16

Agilent Technologies (A) Valuation Check After CRISPR Patent Loss And BioTek Cytation 9 Launch

Simply Wall St.
·
Apr 15

Reaffirming Buy on CRISPR Therapeutics: Conference Engagement and Gene-Editing Leadership Support Attractive Risk‑Reward

TIPRANKS
·
Apr 14

This Nuclear Stock Had Its Best Day Ever. Cathie Wood's ARK Took the Moment to Sell. -- Barrons.com

Dow Jones
·
Apr 11

Is CRISPR Therapeutics (CRSP) Pricing Reflect Its Sharp Five‑Year Share Price Pullback

Simply Wall St.
·
Apr 09

CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
Apr 07

Assessing CRISPR Therapeutics (CRSP) Valuation As Casgevy Revenue And Cash Position Support Its Growth Transition

Simply Wall St.
·
Apr 04

CRISPR Therapeutics announces annual shareholder meeting, releases preliminary proxy statement

Reuters
·
Apr 03